Changes in T lymphocyte subsets predict the efficacy of atezolizumab in advanced non-small cell lung cancer: a retrospective study

BACKGROUND: It has remained unclear how programmed cell death ligand 1 (PD-L1) inhibitors affect peripheral blood lymphocyte (PBL) subsets in patients with advanced non-small cell lung cancer (NSCLC). This study assessed the predictive and prognostic value of PBL subsets in patients with advanced NS...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yuyang, Zhu, Jingjuan, Zhou, Na, Wang, Yun, Zhang, Xiaochun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10636460/
https://www.ncbi.nlm.nih.gov/pubmed/37969284
http://dx.doi.org/10.21037/jtd-23-1169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10636460/
https://www.ncbi.nlm.nih.gov/pubmed/37969284
http://dx.doi.org/10.21037/jtd-23-1169

Ejemplares similares